96 related articles for article (PubMed ID: 12757778)
21. Characterization of monoclonal anti-human factor VII antibody (B101/B1) that recognized three-dimensional structures near Arg at position 79 in the first EGF-like domain.
Takamiya O
Thromb Haemost; 1998 Jan; 79(1):104-9. PubMed ID: 9459333
[TBL] [Abstract][Full Text] [Related]
22. III. Instantaneous inhibition by compound 48/80 of tissue factor-initiated extrinsic coagulation is mediated by the downregulation of factor VII activation.
Chu AJ; Wang ZG; Fox MJ
Arch Biochem Biophys; 2000 May; 377(2):357-65. PubMed ID: 10845714
[TBL] [Abstract][Full Text] [Related]
23. The effect of O-fucosylation on the first EGF-like domain from human blood coagulation factor VII.
Kao YH; Lee GF; Wang Y; Starovasnik MA; Kelley RF; Spellman MW; Lerner L
Biochemistry; 1999 Jun; 38(22):7097-110. PubMed ID: 10353820
[TBL] [Abstract][Full Text] [Related]
24. The Story of Serum Prothrombin Conversion Accelerator, Proconvertin, Stable Factor, Cothromboplastin, Prothrombin Accelerator or Autoprothrombin I, and Their Subsequent Merging into Factor VII.
Girolami A; Cosi E; Santarossa C; Ferrari S; Luigia Randi M
Semin Thromb Hemost; 2015 Jun; 41(4):366-73. PubMed ID: 25973586
[TBL] [Abstract][Full Text] [Related]
25. High-level expression of functional recombinant human coagulation factor VII in insect cells.
Masroori N; Halabian R; Mohammadipour M; Roushandeh AM; Rouhbakhsh M; Najafabadi AJ; Fathabad ME; Salimi M; Shokrgozar MA; Roudkenar MH
Biotechnol Lett; 2010 Jun; 32(6):803-9. PubMed ID: 20213530
[TBL] [Abstract][Full Text] [Related]
26. Purification and characterization of factor VII 304-Gln: a variant molecule with reduced activity isolated from a clinically unaffected male.
O'Brien DP; Gale KM; Anderson JS; McVey JH; Miller GJ; Meade TW; Tuddenham EG
Blood; 1991 Jul; 78(1):132-40. PubMed ID: 2070047
[TBL] [Abstract][Full Text] [Related]
27. Cloning and functional expression of venom prothrombin activator protease from Pseudonaja textilis with whole blood procoagulant activity.
Filippovich I; Sorokina N; St Pierre L; Flight S; de Jersey J; Perry N; Masci PP; Lavin MF
Br J Haematol; 2005 Oct; 131(2):237-46. PubMed ID: 16197456
[TBL] [Abstract][Full Text] [Related]
28. Coagulation Testing in the Core Laboratory.
Winter WE; Flax SD; Harris NS
Lab Med; 2017 Nov; 48(4):295-313. PubMed ID: 29126301
[TBL] [Abstract][Full Text] [Related]
29. Characterization of a cDNA coding for human factor VII.
Hagen FS; Gray CL; O'Hara P; Grant FJ; Saari GC; Woodbury RG; Hart CE; Insley M; Kisiel W; Kurachi K
Proc Natl Acad Sci U S A; 1986 Apr; 83(8):2412-6. PubMed ID: 3486420
[TBL] [Abstract][Full Text] [Related]
30. Demonstration of the extrinsic coagulation pathway in teleostei: identification of zebrafish coagulation factor VII.
Sheehan J; Templer M; Gregory M; Hanumanthaiah R; Troyer D; Phan T; Thankavel B; Jagadeeswaran P
Proc Natl Acad Sci U S A; 2001 Jul; 98(15):8768-73. PubMed ID: 11459993
[TBL] [Abstract][Full Text] [Related]
31. A cyclic pentapeptide derived from the second EGF-like domain of Factor VII is an inhibitor of tissue factor dependent coagulation and thrombus formation.
Orning L; Fischer PM; Hu CK; Agner E; Engebretsen M; Husbyn M; Petersen LB; Orvim U; Llinas M; Sakariassen KS
Thromb Haemost; 2002 Jan; 87(1):13-21. PubMed ID: 11848442
[TBL] [Abstract][Full Text] [Related]
32. Production of coagulation factor VII in human cell lines Sk-Hep-1 and HKB-11.
Corrêa de Freitas MC; Bomfim AS; Mizukami A; Picanço-Castro V; Swiech K; Covas DT
Protein Expr Purif; 2017 Sep; 137():26-33. PubMed ID: 28651975
[TBL] [Abstract][Full Text] [Related]
33. Synthetic peptide analogs of tissue factor and factor VII which inhibit factor Xa formation by the tissue factor/factor VIIa complex.
Rønning HF; Risøen UC; Orning L; Sletten K; Sakariassen KS
Thromb Res; 1996 Oct; 84(2):73-81. PubMed ID: 8897697
[TBL] [Abstract][Full Text] [Related]
34. Solution structure of the N-terminal EGF-like domain from human factor VII.
Muranyi A; Finn BE; Gippert GP; Forsén S; Stenflo J; Drakenberg T
Biochemistry; 1998 Jul; 37(30):10605-15. PubMed ID: 9692950
[TBL] [Abstract][Full Text] [Related]
35. Characterization of a factor VII molecule carrying a mutation in the second epidermal growth factor-like domain.
Kavlie A; Orning L; Grindflek A; Stormorken H; Prydz H
Thromb Haemost; 1998 Jun; 79(6):1136-43. PubMed ID: 9657438
[TBL] [Abstract][Full Text] [Related]
36. Cloning and characterization of a cDNA encoding murine coagulation factor X.
Liang Z; Cooper A; DeFord ME; Carmeliet P; Collen D; Castellino FJ; Rosen ED
Thromb Haemost; 1998 Jul; 80(1):87-91. PubMed ID: 9684791
[TBL] [Abstract][Full Text] [Related]
37. Novel aberrant splicings caused by a splice site mutation (IVS1a+5g>a) in F7 gene.
Ding Q; Wu W; Fu Q; Wang X; Hu Y; Wang H; Wang Z
Thromb Haemost; 2005 Jun; 93(6):1077-81. PubMed ID: 15968391
[TBL] [Abstract][Full Text] [Related]
38. Molecular characterization of a factor VII deficient patient supports the importance of the second epidermal growth factor-like domain.
D'Andrea G; Bossone A; Lupone MR; Peyvandi F; Maisto G; Perricone F; Grandone E; Margaglione M
Haematologica; 2004 Aug; 89(8):979-84. PubMed ID: 15339682
[TBL] [Abstract][Full Text] [Related]
39. High-level production of human blood coagulation factors VII and XI using a new mammalian expression vector.
Kemball-Cook G; Garner I; Imanaka Y; Nishimura T; O'Brien DP; Tuddenham EG; McVey JH
Gene; 1994 Feb; 139(2):275-9. PubMed ID: 8112618
[TBL] [Abstract][Full Text] [Related]
40. Measurement of factor VII and of activated factor VII in healthy individuals and in prothrombin complex concentrates.
Hellstern P; Beeck H; Fellhauer A; Fischer A; Faller-Stöckl B
Thromb Res; 1997 Jun; 86(6):493-504. PubMed ID: 9219329
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
